|

Setidegrasib Clinical Trials

2 actively recruiting trials across 2 locations

Also known as: ASP3082

Pipeline

Phase 1: 1Phase 3: 1

Top Sponsors

  • Astellas Pharma Inc1
  • Astellas Pharma Global Development, Inc.1

Indications

  • Cancer2
  • Metastatic Pancreatic Adenocarcinoma1
  • Metastatic Pancreatic Cancer1
  • Pancreatic Cancer1
  • Solid Tumor1

Duarte, California1 trial

A Study of ASP3082 in Adults With Advanced Solid Tumors

City of Hope National Medical Center

Phase 1

Jacksonville, Florida1 trial

A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer

Baptist MD Anderson Cancer Institute

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.